# Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection

> **NCT01035346** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01035346
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01035346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01035346, "Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01035346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*